FDA — authorised 28 March 2011
- Application: ANDA079129
- Marketing authorisation holder: STRIDES PHARMA
- Status: supplemented
FDA authorised Medicine on 28 March 2011
Yes. FDA authorised it on 28 March 2011; FDA has authorised it.
STRIDES PHARMA holds the US marketing authorisation.